Habel N - Search Results

1

HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma.

Malissen N, Macagno N, Granjeaud S, Granier C, Moutardier V, Gaudy-Marqueste C, Habel N, Mandavit M, Guillot B, Pasero C, Tartour E, Ballotti R, Grob JJ, Olive D. Malissen N, et al. Among authors: habel n. Oncoimmunology. 2019 Sep 25;8(12):e1665976. doi: 10.1080/2162402X.2019.1665976. eCollection 2019. Oncoimmunology. 2019. PMID: 31741766 Free PMC article.

2

An Update on the Role of Ubiquitination in Melanoma Development and Therapies.

Soysouvanh F, Giuliano S, Habel N, El-Hachem N, Pisibon C, Bertolotto C, Ballotti R. Soysouvanh F, et al. Among authors: habel n. J Clin Med. 2021 Mar 8;10(5):1133. doi: 10.3390/jcm10051133. J Clin Med. 2021. PMID: 33800394 Free PMC article. Review.

3

FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.

Habel N, El-Hachem N, Soysouvanh F, Hadhiri-Bzioueche H, Giuliano S, Nguyen S, Horák P, Gay AS, Debayle D, Nottet N, Béranger G, Paillerets BB, Bertolotto C, Ballotti R. Habel N, et al. Cell Death Differ. 2021 Jun;28(6):1837-1848. doi: 10.1038/s41418-020-00710-x. Epub 2021 Jan 18. Cell Death Differ. 2021. PMID: 33462405 Free PMC article.

4

Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.

El-Hachem N, Habel N, Naiken T, Bzioueche H, Cheli Y, Beranger GE, Jaune E, Rouaud F, Nottet N, Reinier F, Gaudel C, Colosetti P, Bertolotto C, Ballotti R. El-Hachem N, et al. Among authors: habel n. Cell Death Differ. 2018 Nov;25(11):2010-2022. doi: 10.1038/s41418-018-0090-y. Epub 2018 Mar 7. Cell Death Differ. 2018. PMID: 29515254 Free PMC article.

5

[No title available]

[No authors listed] [No authors listed] PMID: 33563928

6

Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells.

Bellini L, Strub T, Habel N, Pandiani C, Marchetti S, Martel A, Baillif S, Bailly-Maitre B, Gual P, Ballotti R, Bertolotto C. Bellini L, et al. Among authors: habel n. Cell Death Discov. 2020 Apr 17;6:22. doi: 10.1038/s41420-020-0259-2. eCollection 2020. Cell Death Discov. 2020. PMID: 32337074 Free PMC article.

7

Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance.

Habel N, Hamidouche Z, Girault I, Patiño-García A, Lecanda F, Marie PJ, Fromigué O. Habel N, et al. Cell Death Dis. 2013 Oct 24;4(10):e874. doi: 10.1038/cddis.2013.405. Cell Death Dis. 2013. PMID: 24157868 Free PMC article.

8

ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.

Jullien N, Dieudonné FX, Habel N, Marty C, Modrowski D, Patino A, Lecanda F, Sévère N, Marie PJ. Jullien N, et al. Among authors: habel n. Gene. 2013 May 25;521(1):55-61. doi: 10.1016/j.gene.2013.03.031. Epub 2013 Mar 27. Gene. 2013. PMID: 23541807

9

CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.

Habel N, Stefanovska B, Carène D, Patiño-Garcia A, Lecanda F, Fromigué O. Habel N, et al. BMC Cancer. 2019 Jan 14;19(1):62. doi: 10.1186/s12885-019-5282-4. BMC Cancer. 2019. PMID: 30642298 Free PMC article.

10

Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors.

Habel N, Vilalta M, Bawa O, Opolon P, Blanco J, Fromigué O. Habel N, et al. Oncogene. 2015 Jun 11;34(24):3207-13. doi: 10.1038/onc.2014.232. Epub 2014 Jul 28. Oncogene. 2015. PMID: 25065593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters